HeartBeam Inc is a medical technology company focused on developing higher resolution ambulatory electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company's proprietary and patented technology platform captures the heart's electrical activity from three dimensions and synthesizes a 12-lead ECG from these signals. The company has received U.S. Food and Drug Administration (FDA) clearance for its ECG solutions.
Last trade$0.3347
Day change-$0.0243 (-6.77%)
Day range$0.334 – $0.362
Volume807,780
Market cap$23M
OpenXNAS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$22.79M
Price / earnings
—
Price / book
3.5×
Price / sales
—
EV / sales
—
EV / EBITDA
-0.93×
Profitability
Earnings per share
-$0.29
Return on assets
-229.31%
Return on equity
-277.11%
Dividend yield
0%
Liquidity and leverage
Debt / equity
0×
Current ratio
4.64×
Quick ratio
4.55×
Cash ratio
4.47×
Cash flow
Price / cash flow
—
Price / free cash flow
—
Free cash flow
-$13.43M
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for BEAT, quarterly periods
Line item
Q3 FY2026 Sep 30, 2026
Q2 FY2026 Jun 30, 2026
Q1 FY2026 Mar 31, 2026
Q4 FY2025 Dec 31, 2025
Q3 FY2025 Sep 30, 2025
Q2 FY2025 Jun 30, 2025
Q1 FY2025 Mar 31, 2025
Q4 FY2024 Dec 31, 2024
Revenue
$0
$0
$0
$0
$0
$0
$0
$0
Cost of revenue
$0
$0
$0
$0
$0
$0
$0
$0
Gross profit
$0
$0
$0
$0
$0
$0
$0
$0
Selling, general and administrative
$1.34M
$2.76M
$2.35M
$1.96M
$2.01M
$1.71M
$2.01M
$2.06M
Research and development
$2.12M
$2.33M
$2.37M
$3.35M
$3.28M
$3.33M
$3.49M
$2.89M
Total operating expenses
$3.07M
$5.09M
$4.72M
$5.31M
$5.29M
$5.04M
$5.5M
$4.94M
Operating income
-$3.07M
-$5.09M
-$4.72M
-$5.31M
-$5.29M
-$5.04M
-$5.5M
-$4.94M
Interest expense
$63K
$0
$16K
$0
$36K
$0
$20K
$0
Income before taxes
-$3.01M
-$5.04M
-$4.7M
-$5.3M
-$5.26M
-$4.97M
-$5.48M
-$4.91M
Income taxes
$0
$0
$0
$0
$0
$0
$0
$0
Net income
-$3.01M
-$5.04M
-$4.7M
-$5.3M
-$5.26M
-$4.97M
-$5.48M
-$4.91M
Net income attributable to common shareholders
-$3.01M
-$5.04M
-$4.7M
-$5.3M
-$5.26M
-$4.97M
-$5.48M
-$4.91M
EBITDA
-$3M
-$5.04M
-$4.69M
-$5.29M
-$5.28M
-$5.03M
-$5.5M
-$4.94M
Basic earnings per share
-$0.05
-$0.10
-$0.12
-$0.15
-$0.15
-$0.15
-$0.18
-$0.18
Diluted earnings per share
-$0.05
-$0.10
-$0.12
-$0.15
-$0.15
-$0.15
-$0.18
-$0.18
Recent news
Company coverage with links to the original publishers.
Five companies—VentriPoint Diagnostics, HeartBeam, Heartflow, Hyperfine, and GE Healthcare Technologies—are advancing AI-enabled cardiac diagnostic platforms to address the global heart disease crisis. Recent developments include VentriPoint's partnership with First Light Health for remote Indigenous communities, HeartBeam's collaboration with Mount Sinai on AI-ECG algorithms, Heartflow's new clinical registry data, Hyperfine's breakthrough stroke detection results, and GE Healthcare's role in the EU's COMPASS cardiotoxicity initiative.
A new report reveals the evolving cardiac diagnostics market, highlighting how consumer technology and medical systems are transforming heart monitoring, with a focus on intellectual property and diagnostic capabilities.
HeartBeam reported Q2 2025 results, showing a 23% decrease in cash burn and maintaining progress towards FDA clearance for its 12-lead ECG synthesis software, targeting a pilot launch in Florida and Southern California's concierge medical practices.
Shares of FedEx Corporation (NYSE: FDX) rose sharply in today’s pre-market trading after the company reported better-than-expected earnings for its third quarter and authorized a new $5 billion share repurchase program.
FedEx reported quarterly earnings of $3.86 per share which beat the analyst consensus estimate of $3.45 by 11.88% and represents a 13.2% increase over earnings of $3.41 per share from the same period last year. Quarterly sales came in at $21.7 billion, missing the analyst consensus estimate of $22.04 billion, according to data from Benzinga Pro.
FedEx shares surged 12.4% to $297.72 in pre-market trading
Here are some other stocks moving in pre-market trading.
Gainers
Murano Global Investments PLC (NASDAQ: MRNO) shares rose 266.4% to $35.43 in pre-market trading after falling 46% on Thursday.
Nova LifeStyle, Inc. (NASDAQ: NVFY) rose 62.5% to $2.99 in pre-market trading after gaining around 22% on Thursday.
BIOLASE, Inc. (NASDAQ: BIOL) shares rose 32.8% to $0.1990 in pre-market trading after the company ...
Gainers
Innovative Eyewear, Inc. (NASDAQ: LUCY) jumped 164% to $3.86 after the company announced it launched ChatGPT-enabled smart eyewear.
National CineMedia, Inc. (NASDAQ: NCMI) climbed 81% to $0.2409 after a 13G filing showed a 9.1% passive stake in the company from AMC Entertainment.
IMAC Holdings, Inc. (NASDAQ: BACK) gained 71% to $0.2144. IMAC Holdings and Brain Scientific recently announced a strategic merger to create a synergistic end-to-end neurological solution.
WW International, Inc. (NASDAQ: WW) shares jumped 48.9% to $6.14 after Goldman Sachs upgraded the stock from Neutral to Buy and raised its price target from $3.8 to $13.
ZeroFox Holdings, Inc. (NASDAQ: ZFOX) gained 47.4% to $2.44 after the company announced it partnered with Google Cloud to disrupt phishing attacks and malicious URLs.
Clearmind Medicine Inc. (NASDAQ: CMND) gained 35.4% to $0.5818 after jumping more than 10% on Monday.
Silvergate Capital Corporation (NYSE: SI) surged 33% to $1.85.
Apollomics, Inc. (NASDAQ: APLM) jumped 30.5% to $10.62.
Brookdale Senior Living Inc. (NYSE: BKD) shares gained 23.8% to $3.6899 after the company reported favorable updates to its Q1 financial expectations based upon preliminary, unaudited results.
VBI Vaccines Inc. (NASDAQ: VBIV) jumped 23.8% to $0.1696.
Nogin, Inc. (NASDAQ: NOGN) gained 22.6% to $2.17 following insider buying.
BTCS Inc. (NASDAQ: BTCS) jumped 21.6% to $1.3871.
Cognyte Software Ltd. (NASDAQ: CGNT) gained 21% to $4.14 after reporting upbeat Q4 results.
SciSparc Ltd. (NASDAQ: SPRC) rose 17.2% to $0.5619.
BigBear.ai Holdings, Inc. (NYSE: BBAI) gained 15% to $3.23.
ReShape Lifesciences Inc. (NASDAQ: RSLS) jumped 14.5% to $3.0350. ...
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
No prior dividend records found.
Stock splits
Historical share-structure events and their execution dates.